Y. Voges

Most-cited papers

1. Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells

   M. Michaelis, F. Rothweiler, S. Barth, J. Cinatl +12 more

   2011Cell Death and Disease148 citations Open access

   Semantic Scholar

   Save

2. Identification of flubendazole as potential anti-neuroblastoma compound in a large cell line screen

   M. Michaelis, Bishr Agha, F. Rothweiler, Nadine Löschmann +16 more

   2015Scientific Reports86 citations Open access

   Semantic Scholar

   Save

3. Effects of YM155 on survivin levels and viability in neuroblastoma cells with acquired drug resistance

   Y. Voges, M. Michaelis, F. Rothweiler, T. Schaller +8 more

   2016Cell Death and Disease47 citations Open access

   Semantic Scholar

   Save

4. Testing of SNS-032 in a Panel of Human Neuroblastoma Cell Lines with Acquired Resistance to a Broad Range of Drugs.

   Nadine Löschmann, M. Michaelis, F. Rothweiler, R. Zehner +10 more

   2013Translational Oncology28 citations Open access

   Semantic Scholar

   Save

5. Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines

   M. Michaelis, Y. Voges, F. Rothweiler, F. Weipert +7 more

   2020bioRxiv10 citations Open access

   Semantic Scholar

   Save

6. YM155-Adapted Cancer Cell Lines Reveal Drug-Induced Heterogeneity and Enable the Identification of Biomarker Candidates for the Acquired Resistance Setting

   M. Michaelis, M. Wass, Ian G. Reddin, Y. Voges +8 more

   2020Cancers6 citations Open access

   Semantic Scholar

   Save

7. ABCB1 as predominant resistance mechanism in cells with acquired SNS-032 resistance

   Nadine Löschmann, M. Michaelis, F. Rothweiler, Y. Voges +3 more

   2016OncoTarget6 citations Open access

   Semantic Scholar

   Save

8. Wednesday 29 November 2016: Poster Sessions: Paediatric Oncology: Poster (Board P097)126 - Flubendazole as potential anti-neuroblastoma therapy option

   M. Michaelis, B. Agha, F. Rothweiler, N. Loeschmann +4 more

   20161 citations

   Semantic Scholar

   Save

9. Correction: Human neuroblastoma cells with acquired resistance to the p53 activator RITA retain functional p53 and sensitivity to other p53 activating agents

   M. Michaelis, F. Rothweiler, B. Agha, S. Barth +8 more

   2026Cell Death and Disease0 citations Open access

   Semantic Scholar

   Save

10. Drug-adapted cancer cell lines reveal drug-induced heterogeneity and enable the identification of biomarker candidates for the acquired resistance setting

    M. Michaelis, M. Wass, Ian G. Reddin, Y. Voges +8 more

    2020bioRxiv0 citations Open access

    Semantic Scholar

    Save

11. Flubendazole as potential anti-neuroblastoma therapy option

    M. Michaelis, Bishr Agha, R. Florián, Nadine Löschmann +4 more

    20160 citations

    Semantic Scholar

    Save